ClinicalTrialsFinder

Phase 3 Obstruction Clinical Trials

8 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–8 of 8 trials

Recruiting
Phase 3

Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults

Nasal congestionCommon Cold/Flunasal obstruction
Brainfarma Industria Química e Farmacêutica S/A620 enrolled15 locationsNCT07626437
Recruiting
Phase 3

PREcision MEDicine In Achalasia (PREMEDIA)

Type I AchalasiaType II AchalasiaEGJ Outflow Obstruction Without Spastic/Hypercontractile Features
Northwestern University372 enrolled13 locationsNCT07293650
Recruiting
Phase 3

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer

Thyroid CancerNasolacrimal Duct Obstruction
Vanderbilt University Medical Center100 enrolled1 locationNCT05999630
Recruiting
Phase 3

Optimizing Treatment of Adhesive Small Bowel Obstruction

Adhesive Small Bowel Obstruction
University of California, Los Angeles40 enrolled1 locationNCT06182319
Recruiting
Phase 3

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

HematuriaSame Day DischargeBPH+1 more
Northwestern University138 enrolled1 locationNCT05620784
Completed
Phase 3

Evaluation of Three Doses of Nebulized Epinephrine in Post-Extubation Croup

extubation failureupper airway obstruction
Paulo Sergio Lucas da Silva72 enrolled1 locationACTRN12610000759099
Terminated
Phase 3

The effect of simvastatin, omega-3 fatty acids and antioxidants on lung function in ex-smokers with symptomatic airflow obstruction

airflow obstruction
NHMRC CCRE in Respiratory and Sleep Medicine40 enrolled1 locationACTRN12609000272291
Completed
Phase 3

A randomised double blind placebo controlled trial of infusional subcutaneous octreotide in the management of malignant bowel obstruction at the end of life.

Bowel obstruction in the setting of advanced cancer
Flinders University92 enrolled1 locationACTRN12608000211369